Company overview
SWISSCI provides innovative laboratory solutions for crystallography, Cryo EM, cell culture, data collection, and PCR applications in life sciences and pharma R&D. They manufacture specialized products including MRC 2-well and 3-well crystallization plates, glass bottom optical assay plates for imaging, hanging drop seals, and no-centrifuge ultrafiltration devices. These tools support protein crystallization, sample concentration, and high-clarity imaging with reduced autofluorescence.
SWISSCI Laboratory Solutions - is listed in the NovaPharmaNews Supplier Hub as a Life Science Reagents partner serving United States & Americas. Core focus areas include crystallization plates, cryo em consumables, protein crystallography, ultrafiltration devices, optical assay plates.
Industry categories: Life Science Reagents. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Structured facts
- Website
- https://swissci.com
- Categories
- Life Science Reagents
- Markets served
- United States & Americas
- Keywords
- crystallization plates, cryo em consumables, protein crystallography, ultrafiltration devices, optical assay plates
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What products does SWISSCI offer for protein crystallization?
- SWISSCI offers MRC 2-well and 3-well crystallization plates in 96-well format, hanging drop seals for imaging, and related consumables for crystallography and Cryo EM.
- What are SWISSCI's laboratory diagnostics capabilities?
- SWISSCI is a fully integrated supplier of laboratory diagnostics solutions, managing major international programs with expertise in production for research and diagnostics.
- What unique features do SWISSCI imaging plates provide?
- SWISSCI Glass Bottom optical assay plates feature a unique processing technique that reduces autofluorescence, setting a new benchmark for micro-plate imaging in life sciences.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
